SACHS BRUCE I 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed May 5, 2026
Research Summary
AI-generated summary of this filing
Vertex (VRTX) Director Bruce I. Sachs Receives 2,866-Share Award
What Happened Bruce I. Sachs, a director of Vertex Pharmaceuticals (VRTX), was granted an award of 2,866 derivative shares on May 1, 2026. The filing shows $0.00 per share (no purchase price) and classifies the transaction as an award/acquisition (code A). A footnote indicates the award is fully vested.
Key Details
- Transaction date: 2026-05-01; filing date (Form 4): 2026-05-05 (filed within required two business days).
- Amount: 2,866 shares; price reported: $0.00; total cash exchanged: $0.
- Security type: reported as "Derivative" (award/acquisition).
- Footnote F1: award is fully vested.
- Shares owned after transaction: not specified in the filing.
Context This is a compensation-related award to a company director (common for board pay). The filing does not show a sale or cash purchase, nor indicate any immediate disposition of the shares. Such awards are routine and do not, by themselves, signal the insider’s view on the stock.
Insider Transaction Report
Form 4
SACHS BRUCE I
Director
Transactions
- Award
Stock Option (Right to Buy)
[F1]2026-05-01+2,866→ 2,866 totalExercise: $424.45Exp: 2036-04-30→ Common Stock (2,866 underlying)
Footnotes (1)
- [F1]Fully vested.
Signature
/s/ Christiana Stevenson, Attorney-in-Fact|2026-05-05